GSK Senior VP Rogerio Ribeiro On Trends In Emerging Markets: An Interview With PharmAsia News
This article was originally published in PharmAsia News
Executive Summary
GSK operates in 172 emerging markets, which represented about 22% of the company’s revenues in 2013, and EM Head Rogerio Ribeiro is optimistic about further growth despite challenges in some markets.